PFEIFFER, Tim, Michael J. SCHLEUNING, Jiří MAYER, Karl Heinz HAUDE, Johanna TISCHER, Stefanie BUCHHOLZ, Donald W. BUNJES, Gesine BUG, Ernst HOLLER, Ralf Georg MEYER, Hildegard T. GREINIX, Christof SCHEID, Maximilian CHRISTOPEIT, Susanne SCHNITTGER, Jan BRAESS, Günter SCHLIMOK, Karsten SPIEKERMANN, Arnold GANSER, Hans Jochem KOLB a Çhristof C. SCHMID. Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse. Haematologica/the hematology journal. Pavia: Ferrata Storti Foundation, Vol. 98, č. 4, s. 518-525. ISSN 0390-6078. doi:10.3324/haematol.2012.070235. 2013.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse
Autoři PFEIFFER, Tim (276 Německo, garant), Michael J. SCHLEUNING (276 Německo), Jiří MAYER (203 Česká republika, domácí), Karl Heinz HAUDE (276 Německo), Johanna TISCHER (276 Německo), Stefanie BUCHHOLZ (276 Německo), Donald W. BUNJES (276 Německo), Gesine BUG (276 Německo), Ernst HOLLER (276 Německo), Ralf Georg MEYER (276 Německo), Hildegard T. GREINIX (276 Německo), Christof SCHEID (276 Německo), Maximilian CHRISTOPEIT (276 Německo), Susanne SCHNITTGER (276 Německo), Jan BRAESS (276 Německo), Günter SCHLIMOK (276 Německo), Karsten SPIEKERMANN (276 Německo), Arnold GANSER (276 Německo), Hans Jochem KOLB (276 Německo) a Çhristof C. SCHMID (276 Německo).
Vydání Haematologica/the hematology journal, Pavia, Ferrata Storti Foundation, 2013, 0390-6078.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Itálie
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 5.868
Kód RIV RIV/00216224:14110/13:00068403
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3324/haematol.2012.070235
UT WoS 000319897700015
Klíčová slova anglicky acute granulocytic leukemia; adult; aged; allogeneic stem cell transplantation;
Příznaky Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 11. 10. 2013 15:41.
Anotace
Based on molecular aberrations, in particular the NPM1 mutation (NPM1mut) and the FLT3 internal tandem duplication (Flt3-ITD), prognostic subgroups have been defined among patients with acute myeloid leukemia with normal karyotype. Whereas these subgroups are known to play an important role in outcome in first complete remission, and also in the indication for allogeneic stem cell transplantation, data are limited on their role after transplantation in advanced disease. To evaluate the role of molecular subgroups of acute myeloid leukemia with normal karyotype after allogeneic stem cell transplantation beyond first complete remission, we analyzed the data from 141 consecutive adults (median age: 51.0 years, range 18.4-69.3 years) who had received an allogeneic transplant either in primary induction failure or beyond first complete remission. A sequential regimen of cytoreductive chemotherapy (fludarabine, high-dose AraC, amsacrine) followed by reduced intensity conditioning (FLAMSA-RIC), was uniformly used for conditioning. After a median follow up of three years, overall survival from transplantation was 64+/-4%, 53+/-4% and 44+/-5% at one, two and four years, respectively. Forty patients transplanted in primary induction failure achieved an encouraging 2-year survival of 69%. Among 101 patients transplanted beyond first complete remission, 2-year survival was 81% among patients with the NPM1mut/FLT3wt genotype in contrast to 43% in other genotypes. Higher numbers of transfused CD34+ cells (hazard ratio 2.155, 95% confidence interval 0.263-0.964, P=0.039) and favorable genotype (hazard ratio 0.142, 95% confidence interval: 0.19-0.898, P=0.048) were associated with superior overall survival in multivariate analysis. In conclusion, patients with acute myeloid leukemia with normal karyotype can frequently be rescued after primary induction failure by allogeneic transplantation following FLAMSA-RIC. The prognostic role of NPM1mut/FLT3-ITD based subgroups was carried through after allogeneic stem cell transplantation beyond first complete remission.
VytisknoutZobrazeno: 16. 4. 2024 06:25